{"name": "Pathway Medical Technologies",
 "permalink": "pathway-medical-technologies",
 "crunchbase_url": "http://www.crunchbase.com/company/pathway-medical-technologies",
 "homepage_url": "http://www.pathwaymedical.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "arterial diseases devices",
 "created_at": "Mon Apr 13 21:51:57 UTC 2009",
 "updated_at": "Fri Sep 02 06:19:34 UTC 2011",
 "overview": "\u003Cp\u003EPathway Medical Technologies, Inc. was founded to develop, manufacture and market medical devices for the treatment of arterial disease. The company\u0026#8217;s initial focus is treating peripheral arterial disease (PAD) more quickly, safely and effectively than existing technologies.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       37],
      "assets/images/resized/0004/1072/41072v1-max-150x150.png"],
     [[222,
       56],
      "assets/images/resized/0004/1072/41072v1-max-250x250.png"],
     [[222,
       56],
      "assets/images/resized/0004/1072/41072v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$42.5M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://venturebeat.com/2009/03/30/pathway-medical-lands-generous-40m-to-treat-arterial-disease/",
    "source_description": "Pathway Medical lands generous $40M to treat arterial disease",
    "raised_amount": 42500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 3,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Forbion Capital Partners",
         "permalink": "forbion-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0010/0907/100907v1-max-150x150.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-250x250.png"],
             [[200,
               80],
              "assets/images/resized/0010/0907/100907v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HLM Venture Partners",
         "permalink": "hlm-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               51],
              "assets/images/resized/0005/0315/50315v1-max-150x150.jpg"],
             [[188,
               64],
              "assets/images/resized/0005/0315/50315v1-max-250x250.jpg"],
             [[188,
               64],
              "assets/images/resized/0005/0315/50315v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Latterell Venture Partners",
         "permalink": "latterell-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0005/5132/55132v2-max-150x150.png"],
             [[250,
               36],
              "assets/images/resized/0005/5132/55132v2-max-250x250.png"],
             [[287,
               42],
              "assets/images/resized/0005/5132/55132v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Oxford Bioscience Partners",
         "permalink": "oxford-bioscience-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0005/5118/55118v1-max-150x150.jpg"],
             [[250,
               61],
              "assets/images/resized/0005/5118/55118v1-max-250x250.jpg"],
             [[408,
               100],
              "assets/images/resized/0005/5118/55118v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Giza Venture Capital",
         "permalink": "giza-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               67],
              "assets/images/resized/0001/3882/13882v5-max-150x150.jpg"],
             [[231,
               104],
              "assets/images/resized/0001/3882/13882v5-max-250x250.jpg"],
             [[231,
               104],
              "assets/images/resized/0001/3882/13882v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": null,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.prnewswire.com/news-releases/bayer-healthcare-to-acquire-pathway-medical-technologies-128871843.html",
   "source_description": "Bayer Healthcare to Acquire Pathway Medical Technologies",
   "acquired_year": 2011,
   "acquired_month": 9,
   "acquired_day": 1,
   "acquiring_company":
    {"name": "MEDRAD",
     "permalink": "medrad",
     "image":
      {"available_sizes":
        [[[150,
           53],
          "assets/images/resized/0015/2351/152351v1-max-150x150.jpg"],
         [[221,
           79],
          "assets/images/resized/0015/2351/152351v1-max-250x250.jpg"],
         [[221,
           79],
          "assets/images/resized/0015/2351/152351v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}